VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
VitaNova Life Sciences Corp
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026
- Market cap
- $37.52M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.33 (−6.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
VitaNova Life Sciences Corp grew revenue 22.0% to $3.24M over the twelve months to Jul 31, 2026. Operating income fell 107.1% to -$86.12K, moving the operating margin from 46.0% to -2.7%.
Revenue
$3.24M
+22.0% vs. a year earlier
Operating income
-$86.12K
-107.1% vs. a year earlier
EPS, diluted
-$0.02
-118.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $37.52M
- P/E ratio
- –
- Price to sales
- 11.57
- Price to book
- 19.46
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.24M
- Net income
- -$114.10K
- EPS, diluted
- -$0.02
- Book value per share
- $0.23
- Diluted shares
- 8M
Nine years at a glance
Fiscal years 2017 to 2026 and trailing twelve months, USD
Revenue
$3.24M+22.0% YoY
Gross profit
$872.33K-44.5% YoY
Operating income
-$86.12K-107.1% YoY
Net income
-$114.10K-113.3% YoY
EPS, diluted
-$0.02-118.2% YoY
Reported periodTrailing twelve months